Uses
5-Methoxy-2-(2H-1,2,3-triazol-2-yl)benzoic acid is commonly used as an intermediate in organic synthesis and pharmaceutical chemistry. It can be used as a core structure for drug molecules to modify and synthesize compounds with specific biological activities. In the pharmaceutical field, it is frequently used to prepare the drug molecule suvorexin, the first marketed orexin receptor antagonist, which promotes sleep by increasing drowsiness and improving sleep quality.
Synthesis
A solution of 2-(2-iodo-4-methoxyphenyl)-2H-1,2,3-triazole in tetrahydrofuran was cooled to 0 C, then isopropylmagnesium chloride was added to the resulting reaction mixture at 0 C. The solution was cooled to -20 C, then carbon dioxide (gas) was added to the solution over 30 min. The resulting mixture was cooled to -20 C and then carbon dioxide (gas) was drummed into the solution over a period of 30 minutes. The reaction mixture was then brought back to 8 C and 2 N HCl was added to the resulting reaction mixture.At the end of the reaction the reaction mixture was distilled under reduced pressure at 60 C to remove the THF.The residue was then extracted with TBME and the resulting organic layer was washed with 1 M HCl, and the product was extracted into an aqueous layer with 1 M NaOH. The aqueous layer was filtered with activated carbon and the filtrate was diluted with H2O. The mixture was treated with 32% aqueous hydrochloric acid, the resulting suspension was filtered and the filtrate was washed with H2O. The resulting reaction mixture was dried at 60 C under reduced pressure. Crystallization from toluene or H2O afforded the target molecule 5-methoxy-2-(2H-1,2,3-triazol-2-yl)benzoic acid.